Chief Scientific Officer, BioSpherix, Ltd.
Alicia D. Henn PhD MBA is Chief Scientific Officer for BioSpherix, Ltd. Previously, Dr. Henn was a researcher in the Center for Biodefense Immune Modeling at the University of Rochester and at Vaccinex, LLC. At BioSpherix, Dr. Henn has crafted the company’s first scientific program, collaborating with scientists world-wide to advance cell-based therapies and research. Dr. Henn also established a comprehensive training program for customers using cytocentric cell processing systems. Dr. Henn owns the In Vitro Reproducibility and Physiologic Cell Manufacturing groups on LinkedIn. She also writes the cytocentric blog, promoting clonable, aseptic and physiologically relevant cell environments for better scientific reproducibility and translatability.